The FDA is taking action to protect public health by initiating the process to schedule concentrated synthetic 7-hydroxymitragynine (7-OH) opioid products.
The FDA made clear that natural kratom leaf is not the focus of this action. The focus is on the new wave of concentrated synthetic 7-OH opioid products that are 13 times more potent than morphine and are available in smoke shops and convenience stores across the country. Knowing the difference could save lives.
This video is a commentary for educational and entertainment purposes. It is not intended as a substitute for the advice of a physician or other medical professional. I am sharing my own personal experiences, knowledge, and stories.
